Citadel Advisors
ASTX

Citadel Advisors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Citadel Advisors’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-25,400
Closed -$215K – 7471
2013
Q3 		$215K Buy
25,400
+5,100
+25% +$32.3K ﹤0.01% 4697
2013
Q2 		$83K Buy
+20,300
New +$109K ﹤0.01% 5358

Citadel Advisors's ASTX Position: Q4 2013 in Review

Citadel Advisors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 26,880 shares — an estimated $228K sold.

Citadel Advisors first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $2.79M in Q2 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Citadel Advisors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Citadel Advisors sold 26,880 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $228K.
  • Citadel Advisors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Citadel Advisors's ASTEX PHARMACEUTICALS, INC COM position peaked at $2.79M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Citadel Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.